mybacs Company
Mybacs is a biotechnology company that specializes in the human microbiome and aims to revolutionize the market around intestinal healthcare. The company develops innovative and highly-dosed synbiotic supplements tailored to the individual needs of their customers. Mybacs is a research-driven company with a team of pharmaceutical scientists and physicians. They are a DTC company that focuses on the daily well-being of their customers.
%20.jpg)
Investors
Connections
Founded Date:
2019-01-01
Last Funding Type:
Series A
Headquarters:
Baar, Zug, Switzerland
Investors Number:
2
Technology:
Nutrition
Employee Number:
11-50
Industry:
Wellness & Fitness
Estimated Revenue:
$1M to $10M
Funding Status:
Seed
Investor Type:
For Profit
Total Funding:
$5.4M